Fernando Goldsztein joins The Business of Life podcast by Brazil Journal
“Everyone should take a moment to reflect on how much they’re contributing to a better world.” This is one of the key messages shared by MBI founder Fernando Goldsztein during a powerful conversation with writer and rabbi Nilton Bonder on The Business of Life, a podcast by Brazil Journal—one of Brazil’s leading media platforms. In […]
Advancing pediatric cancer research: Cure Group 4 meeting updates
On January 29, 2025, MBI researchers joined the latest Cure Group 4 Consortium meeting, connecting experts from the US, Canada, and Germany. The team discussed preparations for two upcoming FDA-approved clinical trials and set new research goals. Dr. Gene Hwang, head of Oncology at Children’s National in Washington, D.C., highlighted the impact of these efforts, […]
Accelerating progress: funding hope for childhood brain cancer
Brain tumors are the leading cause of cancer-related deaths in children, with medulloblastoma relapsing in 30% of cases. Current treatments, developed in the 1980s, often cause severe, lifelong side effects—when survival is even possible. Now, hope is within reach. Three groundbreaking clinical trials are ready to launch, but $3 million is needed to fund and […]
Race for Every Child: MBI makes its mark at a very special event
MBI’s first participation in the Race for Every Child, hosted in Washington, D.C., by our partner Children’s National Hospital, was simply sensational…
Valuable connections – A project born from belonging
Fernando Goldsztein, tells how the idea for the project came about and what he expects from these connections. This month, the II Conexões de Valor will take place, this project that had its first edition…
Weathering the storm together
It was a night to celebrate: MBI founder Fernando Goldsztein had the honor of stepping on stage together with MBI partner and medulloblastoma survivor Daniel Scola
A toast (of lemonade) to Ava and her friends
With the support of her family and dedicated friends, Ava Strong, an American girl with brain cancer, raised $225 with her lemonade stand…
MATCHPOINT: Has medulloblastoma met its match?
Duane Mitchell, MD, PhD, co-director of the Preston A. Wells Jr. Center for Brain Tumor Therapy at the University of Florida, is leading the MATCHPOINT trial. The treatment uses adoptive cell therapy…
Trials approved — and starting — in record time
Drs. Duane Mitchell and Elias Sayour of the Cure Group 4 Consortium have received approval from the U.S. Food and Drug Administration (FDA) to test…
You are invited to the Race for Every Child — Race for Every Child
It’s a real race in Washington DC, but you can enter from anywhere in the world — accelerating efforts to raise funds for research and care for children…